Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate |
2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-109476631-B |
titleOfInvention |
Novel derivatives and their use as selective inhibitors of caspase-2 |
abstract |
The present invention relates to compounds of formula (I): wherein P 1 , P 3 , P 4 and P 5 are amino acid residues. The present invention also relates to compounds of formula (I) as caspase-2 inhibitors and their therapeutic use. The present invention also relates to the use of compounds of formula (I) as active base probes to selectively detect caspase-2 activity. |
priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |